Pattern of recurrence after surgery in adenocarcinoma of the gastro-oesophageal junction

European Journal of Surgical Oncology

Volumn 29, Issue 6, 2003, Pages 506-510

  de Manzoni, Giovanni ^a   Pedrazzani, C ^a   Pasini, F ^a   Durante, E ^a   Gabbani, M ^a   Grandinetti, A ^a   Guglielmi, A ^a   Griso, C ^a   Cordiano, C ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Gastro oesophageal junction adenocarcinoma; Recurrence; Siewert classification; Surgical treatment

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER PATIENT; CANCER RECURRENCE; CARDIA CARCINOMA; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERITONEUM; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; TOTAL STOMACH RESECTION;

EID: 0042978484     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(03)00098-2     Document Type: Article

References (27)

1. Devessa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of oesophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-53.
2. Siewert JR, Hoelscher AH, Becker K, Gossner W. Kardiacarcinom: versuch einer therapeutisch relevanten klassifikation. Chirurg 1987; 58: 25-32.
3. Siewert JR, Feith M, Werner M et at. Adenocarcinoma of the esophagogastric junction. Results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000; 234: 353-61.
4. de Manzoni G, Pedrazzani C, Pasini F et al. Results of surgical treatment of adenocarcinoma of the gastric cardia. Ann Thorac Surg 2002; 73: 1035-40.
5. Kodera Y, Yamamura Y, Shimizu Y et al. Adenocarcinoma of the gastroesophageal junction in Japan: relevance of Siewert's classification applied to 177 cases resected at a single institution. J Am Coll Surg 1999; 189: 594-601.
6. Hsu CP, Wu CC, Chen CY et al. Clinical experience in radical lymphadenectomy for adenocarcinoma of the gastric cardia. J Thorac Cardiovasc Surg 1997; 114: 544-51.
7. Fein M, Fuchs KH, Ritter MP et al. Application of the new classification for cancer of the cardia. Surgery 1998; 124: 707-13.
8. Hoelscher AH, Bollschweiler E, Siewert JR. Carcinoma of the gastric cardia. Ann Chir Gynaec 1995; 84: 185-92.
9. Jakl RJ, Miholic J, Koller R et al. Prognostic factors in adenocarcinoma of the cardia. Am J Surg 1995; 169: 316-9.
10. Blomjous JG, Hop WC, Langeenhorst BL et al. Adenocarcinoma of the gastric cardia. Recurrence and survival after resection. Cancer 1992; 70: 569-74.
11. Stassen LP, Bosman FT, Siersema PD et al. Recurrence and survival after resection of adenocarcinoma of the gastric cardia. Rotterdam oesophageal tumour study group. Dis Esoph 2000; 13: 32-8.
12. Mattioli S, Di Simone MP, Ferruzzi L et al. Surgical therapy for adenocarcinoma of the cardia: modalities of recurrence and extension of resection. Dis Esoph 2001; 14: 104-9.
13. Wayman J, Bennett MK, Raimes SA, Griffin SM. The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction. Br J Cancer 2002; 86: 1223-9.
14. Japanese Gastric Cancer Association, The new Japanese Classification of Gastric Carcinoma, 2nd English ed. Gastric Cancer, Vol. 1.; 1998: 1-15.
15. In: Sobin LH, Wittekind C (eds) International Union Against Cancer (UICC): TNM Classification of malignant tumours, 5th ed. New York: Wiley, 1997.
16. Clark GWB, Peters JH, Ireland AP et al. Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma. Ann Thorac Surg 1994; 58: 646-54.
17. Hulscher JBF, van Sandick JW, Tijssen JGP et al. The recurrence pattern of oesophageal carcinoma after transhiatal resection. J Am Coll Surg 2000; 191: 143-8.
18. Hagen JA, DeMeester SR, Peters JH et al. Curative resection for oesophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 2001; 234: 520-31.
19. MacDonald JS, Smalley SR, Benedetti J et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastrooesophageal junction. N Engl J Med 2001; 345: 725-30.
20. Maehara Y, Emi Y, Baba H et al. Recurrences and related characteristics of gastric cancer. Br J Cancer 1996; 74: 975-9.
21. de Manzoni G, Pasini F, Pelosi G et al. The presence of bone marrow cytokeratin-immunoreactive cells does not predict outcome in gastric cancer patients. Br J Cancer 2002; 86: 1047-51.
22. Marrelli D, Roviello F, de Manzoni G et al. Different patterns of recurrence in gastric cancer depending on Lauren's histological type: a lungitudinal study. World J Surg 2002; 26: 1160-5.
23. Sanz L, Gonzalez JJ, Miyar A et al. Pattern of recurrence after oesophageal resection for cancer. Hepatogastroenterology 1999; 46: 2393-7.
24. Walsh TN, Noonan N, Hollywood D et al. A comparison of multimodal therapy and surgery for oesophageal adenocarcinoma. N Engl J Med 1996; 335: 462-7.
25. Keller SM, Ryan LM, Coia LR et al. High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the oesophagus and gastrooesophageal junction. Cancer 1998; 83: 1908-16.
26. Yu W, Whang I, Suh I et al. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg 1998; 228: 347-50.
27. Fujimoto S, Takahashi M, Mutou T et al. Successful intraperitoneal hypertermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer 1999; 85: 529-31.